The global microwave ablation system market was valued at $340.5 million in 2021 and it is expected to reach $1098.4 million at a CAGR of 10.4% between 2022 and 2032. The global rise in cases of liver, lung, bone, and kidney cancer is blamed for the market's expansion. Additionally, it is projected that an increase in the number of procedures utilizing the image-guided device will fuel market growth. Due to technological advancements and a rising interest in minimally invasive procedures, microwave ablation devices are expected to become more widespread shortly.
The global rise in cases of liver, lung, bone, and kidney cancer is blamed for the market's expansion. Additionally, it is projected that an increase in the number of procedures utilizing the image-guided device will fuel market growth. Due to technological advancements and a rising interest in minimally invasive procedures, microwave ablation devices are expected to become more widespread soon. In addition, the tumor is pinpointed using imaging guidance, and then electromagnetic microwaves agitate the water molecules in the surrounding tissue, causing friction and heat and ultimately leading to cellular death via coagulation necrosis.
The drivers driving the global market for microwave ablation devices are the rise in cancer prevalence, decreased procedure costs, and the opportunity for outpatient therapy. The amount of tumor ablation treatments performed with image-guided equipment is also anticipated to grow, driving the global market. Additionally, it is anticipated that the benefits of microwave ablation devices will boost demand for the treatment of tumor cells. These benefits include larger tumor ablation volumes, quicker ablation times, and the ability to use multiple applicators, optimal heating of cystic masses, and reduced procedural pain.
Source: SAI Research
Download Free PDF Sample Request
The development of next-generation ablation goods and technologies, as well as the growing popularity of using RF ablation to treat cancer, has an impact on the market for ablation devices. Growth in healthcare finance from the public and private sectors, the adoption of cutting-edge technology, and an increase in healthcare spending, research and development activities, and investments all have a positive impact on the market for ablation devices. Moreover, AngioDynamics Inc, Medtronic Plc, Person, Medwaves Inc, NeuWave Medical Inc, Emblation Microwave Ltd, Miramar Labs Inc, Symple Surgical, Tactile Medical, and Urologix are a few of the leading companies in the market.
Most of the parts of a microwave ablation device are also parts of an RF ablation device. However, compared to RF ablation devices, microwave ablation devices have several advantages. To do image-guided surgery, several microwave ablation equipment can also be used with CT and ultrasound scanners. Therefore, throughout the anticipated period of 2022 to 2032, these growing elements will drive market expansion.
Based on component type, the accessories segment accounted for the largest share of this market and is also anticipated to propel the market growth during the forecast period. Due to an increase in tumor ablation procedures, this sector is also anticipated to lead the microwave ablation device market in terms of revenue. These antennae have several benefits and clinical uses, and they also transfer energy to the tissue. To provide a large and repeatable ablation zone, a single treatment typically requires numerous antennae. The antenna's main characteristics are its low invasiveness and excellent efficiency in penetrating deep into tissues to create larger active heating ablation zones. Major corporations are also involved in the manufacturing and promotion of cutting-edge antennae. For instance, to track the real-time position of antennae, Medtronic has created The Emprint SX navigation antennae that are outfitted with electromagnetic sensors.
In terms of application type, the oncology category has dominated the market growth over the past few years. The oncology market is anticipated to be driven by the rising incidence of cancer, rising healthcare costs associated with the research and development of cancer treatments and solutions, and the expanding use of ablation therapies. Due to the widespread use of these devices in the treatment of tumors that are typically smaller than five inches in diameter and most frequently affect the liver, the liver cancer segment is predicted to dominate the global market. The growing acceptance of RF ablation as a cancer treatment as well as the launch of next-generation ablation products and technology also has an impact on the market for microwave ablation equipment.
Geographically, the North American region has dominated the market and is also projected to hold its dominant position over the forecast period from 2022 to 2032. The widespread use of microwave ablation technology in primary care settings, improved accessibility, and high healthcare expenses in countries with efficient payment systems all contribute to this. Additionally, due to structural changes brought on by aging, the senior population is more prone to several chronic diseases, which is increasing the demand for treatment techniques that will assist companies to succeed in the North American market. On the other hand, the Asia-Pacific region is also estimated to become the second-largest market in the future. Due to the obvious rising senior population in China and Japan, the market for microwave ablation devices is anticipated to grow faster in Asia-Pacific than in other regions.
According to the study, key players such as AngioDynamics (U.S), Emblation Ltd (U.K), Huber+Suhner (Switzerland), Johnson and Johnson (U.S), Medtronic Plc (Ireland), Medwaves (U.S), Miramar Labs (U.S), Mermaid Medical (Denmark), Pearson Medical Technologies (U.S), Siemens (Germany), Symple Surgical (U.S), Terumo Corporation (Japan), Urologix (U.S), Vision Medical (India), among others are leading the global microwave ablation system market.
Report Coverage | Details |
Market Size in 2021 | US$ 340.5 Million |
Market Volume Projection by 2032 | US$ 1098.4 Million |
Forecast Period 2022 to 2032 CAGR | 10.4% |
Base Year: | 2021 |
Historical Data | 2019, 2020 and 2021 |
Forecast Period | 2022 to 2032 |
Segments covered |
By Component Type: Generator, Power Distribution System, Accessories & Others By Application Type: Oncology, Cardiology, Urology, Orthoped |
Geographies covered |
North America, Europe, Asia-Pacific, LAMEA |
Companies covered | AngioDynamics (U.S), Emblation Ltd (U.K), Huber+Suhner (Switzerland), Johnson and Johnson (U.S), Medtronic Plc (Ireland), Medwaves (U.S), Miramar Labs (U.S), Mermaid Medical (Denmark), Pearson Medical Technologies (U.S), Siemens (Germany), Symple Surgical (U.S), Terumo Corporation (Japan), Urologix (U.S), Vision Medical (India), among others. |
The Global Microwave Ablation System Market – by Component Type:
The Global Microwave Ablation System Market – by Application Type:
The Global Microwave Ablation System Market – by Regions:
Customization options available to meet your custom research requirements :